Takeda

[forum discussion]Takeda Layoffs Imminent
[forum discussion]Takeda Layoffs Imminent
Cafepharma Message Boards
Takeda
layoffs
Flag link:
Chris Weber, Takeda CEO, interviewed on his managerial style and Takeda’s pipeline
Chris Weber, Takeda CEO, interviewed on his managerial style and Takeda’s pipeline
GoinPharma
Chris Weber
Takeda
Pharma CEOs
Flag link:
Takeda announces clinical trial for anti-Zika vaccine
Takeda announces clinical trial for anti-Zika vaccine
GoinPharma
Takeda
clinical trials
vaccines
Zika virus
Zika vaccine
TAK-426
Flag link:
Takeda pushes U.S.-backed Zika vaccine into the clinic
Takeda pushes U.S.-backed Zika vaccine into the clinic
Fierce Pharma
Takeda
Zika virus
vaccines
Zika vaccine
TAK-426
Flag link:
Takeda spins off cancer assets to incubated startup
Takeda spins off cancer assets to incubated startup
Fierce Biotech
Takeda
Chordia Therapeutics
spinoffs
cancer
Flag link:
Takeda pursuing needle-free delivery for its top-selling biologic
Takeda pursuing needle-free delivery for its top-selling biologic
BioPharma Dive
Takeda
needle free delivery
Portal Instruments
devices
Entyvio
Flag link:
Watch out Sanofi: Takeda’s new data on dengue vaccine is good news for PhIII trial
Watch out Sanofi: Takeda’s new data on dengue vaccine is good news for PhIII trial
Endpoints
Sanofi
Takeda
vaccines
dengue
TAK-003
Flag link:
Takeda partner Finch joins forces with Crestovo, leaping into a late-stage microbiome study
Takeda partner Finch joins forces with Crestovo, leaping into a late-stage microbiome study
Endpoints
Takeda
Finch Therapeutics
Crestovo
C. difficile
microbiome
CP101
Flag link:
Takeda is beefing up its NASH pipeline with a $470M discovery deal with HemoShear
Takeda is beefing up its NASH pipeline with a $470M discovery deal with HemoShear
Endpoints
Takeda
NASH
drug discovery
HemoShear
R&D
Flag link:
Why Takeda thinks partnerships can revive innovation in pharma
Why Takeda thinks partnerships can revive innovation in pharma
Drug Delivery Business News
Takeda
innovation
partnerships
Flag link:
The race for a Zika vaccine slows, a setback for efforts to head off future outbreaks
The race for a Zika vaccine slows, a setback for efforts to head off future outbreaks
Stat
Zika vaccine
Takeda
Sanofi Pasteur
drug development
Flag link:
Takeda, Johnson & Johnson and more join Clara Health's Boston-based patient empowerment push
Takeda, Johnson & Johnson and more join Clara Health's Boston-based patient empowerment push
Fierce Pharma
Takeda
JNJ
Clara Health
Amylyx Pharmaceuticals
patients
Boston
Flag link:
Takeda partners with Noile-Immune on next-gen CAR-T pipeline for solid tumors
Takeda partners with Noile-Immune on next-gen CAR-T pipeline for solid tumors
Endpoints
Takeda
Noile-Immune
CAR-T
solid tumors
Flag link:
Parkinson's Now a Hot Therapeutic Area: What's Up Lately?
Parkinson's Now a Hot Therapeutic Area: What's Up Lately?
Yahoo/Zacks.com
Parkinson's Disease
Novartis
Teva Pharmaceutial
UCB Pharma
MEDI1341
AstraZeneca
Takeda
PRX002
Prothena
Roche
Acorda
Inbrija
Adamas Pharmaceuticals
Gocovri
Flag link:
AstraZeneca auctions off rights to another pipeline drug as Takeda grabs $400M Parkinson’s deal
AstraZeneca auctions off rights to another pipeline drug as Takeda grabs $400M Parkinson’s deal
Endpoints
AstraZeneca
Takeda
MEDI1341
Parkinson's Disease
Flag link:
Samsung Bioepis switches gears, moves from knockoffs to new drugs with fast-changing Takeda
Samsung Bioepis switches gears, moves from knockoffs to new drugs with fast-changing Takeda
Endpoints
Samsung Bioepis
Takeda
drug development
TAK-671
pancreatitis
Flag link:
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
Motley Fool
biotech
M&A
JNJ
Actelion
Takeda
Ariad Pharmaceuticals
Gilead Sciences
Pfizer
Amgen
Flag link:
Takeda partners to develop novel oncology therapies
Takeda partners to develop novel oncology therapies
Drug Delivery Business News
Takeda
Molecular Templates
Millenium
oncology
drug development
Flag link:
Tesaro partners with Takeda in Asia, bagging a $340M deal for Zejula
Tesaro partners with Takeda in Asia, bagging a $340M deal for Zejula
Endpoints
Tesaro
Takeda
Japan
Zejula
Flag link:
Takeda, BioSurfaces collab on GI drug-delivery devices
Takeda, BioSurfaces collab on GI drug-delivery devices
Drug Delivery Business News
Takeda
BioSurfaces
GI disease
drug delivery
R&D
Flag link:

Pages